title: [Conservative treatment of a hip prosthesis infection due to methicillin-resistant Staphylococcus aureus using prolonged antibiotic therapy based on linezolid followed by daptomycin].
authors.affiliation: Service des Maladies Infectieuses et Tropicales. CHU Hôtel Dieu, 44093 Nantes cedex 1, France. olivier.grossi@chu-nantes.fr
authors.forename: O
authors.initials: O
authors.lastname: Grossi
authors.forename: J P
authors.initials: JP
authors.lastname: Talarmin
authors.forename: D
authors.initials: D
authors.lastname: Boutoille
authors.forename: R
authors.initials: R
authors.lastname: Frioux
authors.forename: S
authors.initials: S
authors.lastname: Corvec
authors.forename: F
authors.initials: F
authors.lastname: Raffi
mesh_terms: D000081:Acetamides / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D000369:Aged, 80 and over; D000758:Anesthesia; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D016470:Bacteremia / Q000188:drug therapy / Q000382:microbiology; D001855:Bone Marrow Diseases / Q000139:chemically induced; D015897:Comorbidity; D000075202:Contraindications; D017576:Daptomycin / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005839:Gentamicins / Q000008:administration & dosage / Q000627:therapeutic use; D006622:Hip Prosthesis / Q000009:adverse effects*; D006801:Humans; D000069349:Linezolid; D008297:Male; D055624:Methicillin-Resistant Staphylococcus aureus / Q000187:drug effects* / Q000302:isolation & purification; D023303:Oxazolidinones / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D016459:Prosthesis-Related Infections / Q000188:drug therapy* / Q000382:microbiology; D012293:Rifampin / Q000008:administration & dosage / Q000627:therapeutic use; D013203:Staphylococcal Infections / Q000188:drug therapy* / Q000382:microbiology; D018746:Systemic Inflammatory Response Syndrome / Q000188:drug therapy / Q000209:etiology; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000008:administration & dosage / Q000627:therapeutic use
chemical_list: D000081:Acetamides; D000900:Anti-Bacterial Agents; D005839:Gentamicins; D023303:Oxazolidinones; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D000069349:Linezolid; D017576:Daptomycin; D012293:Rifampin